The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
Open Access
- 17 November 2011
- journal article
- Published by Wiley in ISRN Obstetrics and Gynecology
- Vol. 2011, 1-4
Abstract
Letrozole, an aromatase inhibitor, has been demonstrated to be effective as an ovulation induction and controlled ovarian hyperstimulation agent. However, dose administration has generally been limited to 5 days at 2.5 to 7.5 mg daily. We undertook a retrospective review of over 900 treatment cycles using letrozole in doses as high as 12.5 mg per day. Results indicate that such doses do indeed offer benefit to patients; in that there is increased follicular growth and a higher number of predicted ovulations with higher doses of the drug. However, increasing doses does not produce a detrimental effect upon endometrial thickness. High-dose letrozole may be of value in women who fail to respond adequately to lower doses. Furthermore, randomized trials are needed to determine whether high-dose letrozole might actually be optimal as a starting dose for certain treatment groups.Keywords
This publication has 22 references indexed in Scilit:
- Letrozole for ovulation induction and controlled ovarian hyperstimulationCurrent Opinion in Obstetrics and Gynecology, 2010
- Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cyclesFertility and Sterility, 2009
- A randomized trial of superovulation with two different doses of letrozoleFertility and Sterility, 2006
- An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestaneCancer, 2002
- Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1European Journal of Cancer, 1999
- Androgens stimulate early stages of follicular growth in the primate ovary.Journal of Clinical Investigation, 1998
- The role of gonadotropins in ovulation inductionAmerican Journal of Obstetrics and Gynecology, 1995
- Intraovarian Regulation: The Proposed Role of Insulin-like Growth FactorsAnnals of the New York Academy of Sciences, 1993
- Interface between Extra‐ and Intraovarian Factors in Polycystic Ovarian SyndromeAnnals of the New York Academy of Sciences, 1993
- The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1993